ArrowMark Colorado Holdings LLC Sells 127,000 Shares of Constellium SE $CSTM

ArrowMark Colorado Holdings LLC decreased its holdings in shares of Constellium SE (NYSE:CSTMFree Report) by 21.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 451,913 shares of the industrial products company’s stock after selling 127,000 shares during the period. ArrowMark Colorado Holdings LLC owned approximately 0.33% of Constellium worth $6,724,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the stock. EverSource Wealth Advisors LLC boosted its holdings in Constellium by 578.6% during the third quarter. EverSource Wealth Advisors LLC now owns 2,348 shares of the industrial products company’s stock worth $35,000 after purchasing an additional 2,002 shares during the last quarter. KBC Group NV bought a new stake in Constellium during the 2nd quarter worth approximately $56,000. Gordian Capital Singapore Pte Ltd purchased a new stake in shares of Constellium in the 3rd quarter valued at about $85,000. EMC Capital Management bought a new stake in shares of Constellium during the 2nd quarter worth $135,000. Finally, PharVision Advisers LLC bought a new stake in Constellium in the 2nd quarter worth approximately $147,000. Hedge funds and other institutional investors own 92.59% of the company’s stock.

Insider Activity at Constellium

In other Constellium news, SVP Nicolas Brun sold 17,701 shares of the firm’s stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $24.67, for a total transaction of $436,683.67. Following the transaction, the senior vice president owned 103,466 shares of the company’s stock, valued at approximately $2,552,506.22. This trade represents a 14.61% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Jack Q. Guo sold 41,717 shares of Constellium stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $25.87, for a total value of $1,079,218.79. Following the completion of the transaction, the chief financial officer owned 190,879 shares in the company, valued at $4,938,039.73. This represents a 17.94% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 214,543 shares of company stock worth $5,565,129 over the last quarter.

Constellium Stock Performance

Constellium stock opened at $24.65 on Monday. The company has a debt-to-equity ratio of 1.96, a current ratio of 1.29 and a quick ratio of 0.51. The company’s 50-day moving average is $23.73 and its 200 day moving average is $18.85. Constellium SE has a 1-year low of $7.32 and a 1-year high of $27.41. The firm has a market capitalization of $3.33 billion, a P/E ratio of 12.77 and a beta of 1.48.

Constellium (NYSE:CSTMGet Free Report) last released its earnings results on Wednesday, February 18th. The industrial products company reported $0.80 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.44. The business had revenue of $2.20 billion during the quarter, compared to the consensus estimate of $2.05 billion. Constellium had a return on equity of 32.14% and a net margin of 3.23%.The business’s revenue for the quarter was up 27.9% compared to the same quarter last year. During the same period last year, the company earned ($0.34) earnings per share. Research analysts forecast that Constellium SE will post 1.1 EPS for the current year.

Constellium declared that its Board of Directors has authorized a stock buyback program on Thursday, March 12th that allows the company to repurchase $300.00 million in outstanding shares. This repurchase authorization allows the industrial products company to buy up to 8.8% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s management believes its shares are undervalued.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. Deutsche Bank Aktiengesellschaft raised their target price on shares of Constellium from $25.00 to $28.00 and gave the stock a “buy” rating in a report on Thursday, February 19th. Wells Fargo & Company raised their price target on Constellium from $25.00 to $29.00 and gave the company an “overweight” rating in a report on Thursday, February 19th. Weiss Ratings reissued a “hold (c)” rating on shares of Constellium in a research report on Monday, December 29th. BMO Capital Markets boosted their price target on Constellium from $25.00 to $30.00 and gave the company an “outperform” rating in a research note on Wednesday, February 18th. Finally, JPMorgan Chase & Co. upped their price target on Constellium from $26.00 to $29.00 and gave the stock an “overweight” rating in a research report on Thursday, February 19th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, Constellium has an average rating of “Buy” and a consensus price target of $29.00.

Read Our Latest Research Report on Constellium

Key Headlines Impacting Constellium

Here are the key news stories impacting Constellium this week:

  • Positive Sentiment: Board approved a new $300 million share buyback (replacing the prior program) that authorizes repurchases of ~8.8% of shares; buybacks are a direct capital‑return catalyst and signal management thinks the shares are undervalued. The program becomes effective after the 2026 AGM (May 21) and runs to Dec 31, 2028. Constellium Board Authorizes a New $300 million Share Repurchase Program
  • Positive Sentiment: Analysts and research outlets have raised 2026 earnings and cash‑flow expectations after solid quarterly results, which supports a re‑rating and further upside potential. Upgrades and higher price targets from multiple houses are driving positive sentiment. Constellium Surges 101.5% in a Year
  • Positive Sentiment: Operational momentum in the Packaging & Automotive unit (rising shipments plus higher aluminum prices) is boosting near‑term revenue and margin outlook, supporting the recent earnings/cash‑flow beats. Packaging & Automotive Momentum
  • Positive Sentiment: Momentum screens and valuation checks (Zacks coverage) flag CSTM as a stock with rapid price appreciation but still an attractive P/E vs. peers — this combination attracts momentum and value‑oriented funds. Attractively Priced Despite Momentum
  • Neutral Sentiment: Institutional flows show active repositioning (several funds increasing stakes), which validates interest but is not an immediate catalyst by itself—watch 13F and fund filings for continued accumulation. MarketBeat Institutional Holdings
  • Negative Sentiment: Multiple insider sales by senior executives (including recent filings showing sales by Stephane Corre and SVP Marcus Becker) were disclosed this week; while routine, the aggregate reported selling (~$2.6M in filings cited by coverage) can create short‑term selling pressure or raise questions for some investors. Insider Selling Alerts

Constellium Company Profile

(Free Report)

Constellium SE is a global leader in the design and manufacture of high-performance aluminum products and solutions. The company serves key markets including aerospace, automotive, and packaging, offering advanced rolled and extruded aluminum sheet, plate and structural components. Its product portfolio encompasses precision-engineered parts for commercial and military aircraft, automotive body structures and closures, beverage and specialty packaging, as well as industrial and structural applications.

Established in 2011 through the consolidation of Rio Tinto Alcan’s rolled-products and engineered-products businesses, Constellium has built a reputation for innovation in lightweighting and sustainability.

See Also

Institutional Ownership by Quarter for Constellium (NYSE:CSTM)

Receive News & Ratings for Constellium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Constellium and related companies with MarketBeat.com's FREE daily email newsletter.